Johnson and Johnson said Friday that the independent safety panel, the Data and Safety Monitoring Board, has recommended that it resumed trial recruitment after finding no evidence that the vaccine caused a volunteer to fall ill.
強生公司週五表示,獨立的安全小組--數據和安全監測委員會在發現沒有證據表明疫苗導致志願者生病後,建議恢復試驗招募。